News Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jul 10, 2019
BEDFORD, Mass.--(BUSINESS WIRE)--Jul. 10, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its second-quarter 2019 financial results after the close...
-
Jul 8, 2019Industry veteran brings extensive experience leading business development groups
BEDFORD, Mass.--(BUSINESS WIRE)--Jul. 8, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on...
-
Jun 5, 2019
BEDFORD, Mass.--(BUSINESS WIRE)--Jun. 5, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on...
-
May 13, 2019
BEDFORD, Mass.--(BUSINESS WIRE)--May 13, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on...
-
May 6, 2019
BEDFORD, Mass.--(BUSINESS WIRE)--May 6, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its...
-
May 2, 2019
BEDFORD, Mass.--(BUSINESS WIRE)--May 2, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its...
-
May 2, 2019Total Revenue Increased 16% Year-over-Year
BEDFORD, Mass.--(BUSINESS WIRE)--May 2, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its...
-
Apr 30, 2019Seasoned commercial leader to oversee hybrid commercial organization and upcoming launch of Bone Repair Surgical Therapy in the U.S.
BEDFORD, Mass.--(BUSINESS WIRE)--Apr. 30, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on...
-
Apr 18, 2019
BEDFORD, Mass.--(BUSINESS WIRE)--Apr. 18, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its first-quarter 2019 financial results after the close of...
-
Apr 3, 2019
BEDFORD, Mass.--(BUSINESS WIRE)--Apr. 3, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on...
-
Mar 18, 2019Industry veteran brings extensive experience leading high-performing R&D groups
BEDFORD, Mass.--(BUSINESS WIRE)--Mar. 18, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on...
-
Mar 11, 2019
BEDFORD, Mass.--(BUSINESS WIRE)--Mar. 11, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics and regenerative medicines company specializing in therapeutics based on...
-
Feb 21, 2019Strong Bottom Line Performance with $0.54 Diluted EPS for Fourth Quarter of 2018
BEDFORD, Mass.--(BUSINESS WIRE)--Feb. 21, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on...
-
Feb 7, 2019
BEDFORD, Mass.--(BUSINESS WIRE)--Feb. 7, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its fourth-quarter and full-year 2018 financial results...
-
Jan 16, 2019
BEDFORD, Mass.--(BUSINESS WIRE)--Jan. 16, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on...
-
Dec 12, 2018
BEDFORD, Mass.--(BUSINESS WIRE)--Dec. 12, 2018-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on...
-
Dec 4, 2018Company Expands HYALOFAST Commercial Reach in Asia, the Middle East and Latin America
BEDFORD, Mass.--(BUSINESS WIRE)--Dec. 4, 2018-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on...
-
Oct 24, 2018Long-Serving DirectorSteven Wheeler to Retire from Board in February 2019
BEDFORD, Mass.--(BUSINESS WIRE)--Oct. 24, 2018-- Anika Therapeutics, Inc. (NASDAQ: ANIK) (“Anika” or the “Company”), a global, integrated orthopedic and regenerative medicines company...
-
Oct 24, 2018CINGAL Drives Strong International Viscosupplement Revenue Growth
BEDFORD, Mass.--(BUSINESS WIRE)--Oct. 24, 2018-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on...
-
Oct 10, 2018Anika to Issue Third-Quarter 2018 Financial Results and Business Highlights on Wednesday, October 24
BEDFORD, Mass.--(BUSINESS WIRE)--Oct. 10, 2018-- Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its third-quarter 2018 financial results after the close of...
-
Sep 5, 2018
BEDFORD, Mass.--(BUSINESS WIRE)--Sep. 5, 2018-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on...
-
Sep 5, 2018
BEDFORD, Mass.--(BUSINESS WIRE)--Sep. 5, 2018-- Anika Therapeutics, Inc. (NASDAQ: ANIK) (“Anika” or the “Company”), a global, integrated orthopedic and regenerative medicines company...
-
Jul 25, 2018Solid Top and Bottom Line Performance with 8% Product Revenue Growth and $0.68 Diluted EPS
BEDFORD, Mass.--(BUSINESS WIRE)--Jul. 25, 2018-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on...
-
Jul 11, 2018
BEDFORD, Mass.--(BUSINESS WIRE)--Jul. 11, 2018-- Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its second-quarter 2018 financial results after the close...
-
Jun 19, 2018CINGAL 16-02 study did not achieve statistical significance at primary endpoint of 26 weeks in active comparator study; Company committed to working closely with regulators to gain U.S. approval
BEDFORD, Mass.--(BUSINESS WIRE)--Jun. 19, 2018-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on...